Update in migraine preventive treatment-Reference-Cited by-同舟云学术

Update in migraine preventive treatment

Published:2020 Issue: Volume: Page:1-27
ISSN:0079-6123
Container-title:Progress in Brain Research
language:
Short-container-title:

Author:

Lai Tzu-Hsien,Huang Tzu-Chou

Publisher

Elsevier

Reference149 articles.

1. Flunarizine for the prevention of migraine—a new look at an old drug;Abu-Arafeh;Dev. Med. Child Neurol.,2012

2. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting;Adelman;Headache,2000

3. Fluoxetine prophylaxis of migraine;Adly;Headache,1992

4. Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double-blind studies;Ailani;Eur. J. Neurol.,2020

5. The American headache society position statement on integrating new migraine treatments into clinical practice;American Headache Society;Headache,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

2. Safety Profile of Botulinum Toxin for Migraine Headache Prophylaxis: A Systematic Review and Meta-analysis;Annals of Military and Health Sciences Research;2023-11-27

3. Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group clinical trials;Headache: The Journal of Head and Face Pain;2023-08-21

4. Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration;Journal of Comparative Effectiveness Research;2023-07

5. Calcitonin-Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention; Literature Review;World Journal of Environmental Biosciences;2021